Address: 301 A-Leela Business Park,M.V. Road, Andheri
Tel: +91 22 5677 4242
Quintiles Transnational is a pharmaceutical services company offering clinical, commercial, consulting and capital services. The Quintiles network consists of more than 20,000 employees in 60 countries.
Quintiles manages clinical trials on behalf of pharmaceutical customers, and provides the following services:
Management of clinical trials, data, projects and providing laboratory services
Providing customers with sales force, product and brand solutions.
Providing data-driven recommendations to help customers achieve success.
Creating strategic partnerships through financing and operational solutions.
Quintiles India is located amidst a rapidly growing local pharmaceutical market. With five offices spread across the country, we help clients take advantage of a well-established corporate infrastructure, government policies favoring R&D, growth in the health insurance sector, and tertiary care and teaching hospitals available for trials.
Other advantages: Quintiles India has solid relationships with leading medical centers and experienced English-speaking investigators. All studies are conducted to FDA and ICH GCP standards. Urban India’s literate population provides fast, efficient access to broad population groups with common and special disease profiles, allowing for rapid patient recruitment and faster study start-ups.
Quintiles helped develop or commercialize all of 2009’s top 50 best selling drugs or compounds and nearly 90% of all breakthrough products released on the market between 1996 and 2008.
Key Services in India:
Access to patients
Central laboratory services
Clinical monitoring and site management
Data management offering a functional service provider (FSP) business model
ECG monitoring services
Access through Our India Team to Quintiles Worldwide:
Over the years, multinational corporations (MNCs) have increasingly been penetrating the Indian pharmaceutical…
India is clearly a new location for Cockram, and what brought you here was your loyal customer Pfizer. After 3…
Dilip Surana of family-run Indian generics giant Micro Labs talks company performance, the evolution of the Indian…
Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front…
You have very successfully executed a vision that you have had for the company since it was a 200 Rs Cr turnover,…
When Astellas announced to expand its presence in India in 2009, you were already speaking of the company’s…
What probably best explains the contrasts in the Indian pharmaceutical landscape is the fact that India can take…
Watson is one the largest generic players in the US but the international presence of the company is still…